Literature DB >> 26920591

Clinical benefit of high-sensitivity cardiac troponin I in the detection of exercise-induced myocardial ischemia.

Gino Lee1, Raphael Twerenbold1, Yunus Tanglay1, Tobias Reichlin1, Ursina Honegger1, Max Wagener2, Cedric Jaeger1, Maria Rubini Gimenez1, Thomas Hochgruber2, Christian Puelacher1, Milos Radosavac1, Philipp Kreutzinger1, Fabio Stallone1, Petra Hillinger1, Lian Krivoshei1, Thomas Herrmann1, Romy Mayr3, Michael Freese1, Damian Wild4, Katharina M Rentsch5, John Todd6, Stefan Osswald1, Michael J Zellweger1, Christian Mueller7.   

Abstract

BACKGROUND: A pilot study using a novel high-sensitivity cardiac troponin I (hs-cTnI) assay suggested that cTnI might be released into blood during exercise-induced myocardial ischemia. We investigated the potential clinical value of this signal.
METHODS: We included 819 patients with suspected exercise-induced myocardial ischemia referred for rest/bicycle myocardial perfusion single-photon emission computed tomography. The treating cardiologist used all available clinical information to quantify clinical judgment regarding the presence of myocardial ischemia using a visual analog scale twice: prior and after stress testing. High-sensitivity cTnI measurements were obtained before, immediately after peak stress, and 2 hours after stress testing in a blinded manner. Myocardial ischemia was adjudicated using perfusion single-photon emission computed tomography and coronary angiography findings.
RESULTS: Exercise-induced myocardial ischemia was detected in 278 (34%) patients. High-sensitivity cTnI levels were significantly higher at all time points in patients with myocardial ischemia as compared with those without (P < .001 for all). Combining clinical judgment prior exercise testing with baseline hs-cTnI levels increased diagnostic accuracy as quantified by the area under the receiver operating characteristics curve (AUC) from 0.672 to 0.757 (P < .001). Combining clinical judgment after exercise testing (AUC 0.704) with baseline or poststress hs-cTnI levels also increased the diagnostic accuracy (AUC 0.761-0.771, P < .001 for all). In contrast, exercise-induced changes in hs-cTnI during exercise did not seem useful, as they were small and similar in patients with or without myocardial ischemia.
CONCLUSIONS: High-sensitivity cTnI concentrations at rest and after exercise, but not its exercise-induced changes, provide substantial incremental value to clinical judgment including exercise electrocardiography regarding the presence of myocardial ischemia.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26920591     DOI: 10.1016/j.ahj.2015.11.010

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  11 in total

1.  Relation of High-sensitivity Cardiac Troponin I Elevation With Exercise to Major Adverse Cardiovascular Events in Patients With Coronary Artery Disease.

Authors:  Bruno B Lima; Muhammad Hammadah; Jeong Hwan Kim; Irina Uphoff; Amit Shah; Oleksiy Levantsevych; Zakaria Almuwaqqat; Kasra Moazzami; Samaah Sullivan; Laura Ward; Yan Sun; Michael Kutner; Yi-An Ko; David S Sheps; Agim Beshiri; Gillian Murtagh; J Douglas Bremner; Viola Vaccarino; Arshed A Quyyumi
Journal:  Am J Cardiol       Date:  2020-09-15       Impact factor: 2.778

2.  Coronary Atherosclerosis, Cardiac Troponin, and Interleukin-6 in Patients With Chest Pain: The PROMISE Trial Results.

Authors:  Maros Ferencik; Thomas Mayrhofer; Michael T Lu; Daniel O Bittner; Hamed Emami; Stefan B Puchner; Nandini M Meyersohn; Alexander V Ivanov; Elizabeth C Adami; Deepak Voora; Geoffrey S Ginsburg; James L Januzzi; Pamela S Douglas; Udo Hoffmann
Journal:  JACC Cardiovasc Imaging       Date:  2022-05-11

3.  Atherosclerotic Cardiovascular Disease Risk Stratification Based on Measurements of Troponin and Coronary Artery Calcium.

Authors:  Yader Sandoval; Suzette J Bielinski; Lori B Daniels; Michael J Blaha; Erin D Michos; Andrew P DeFilippis; Moyses Szklo; Christopher deFilippi; Nicholas B Larson; Paul A Decker; Allan S Jaffe
Journal:  J Am Coll Cardiol       Date:  2020-07-28       Impact factor: 24.094

4.  High-Sensitivity Cardiac Troponin After Cardiac Stress Test: A Systematic Review and Meta-Analysis.

Authors:  Eslam Samaha; Audrey Avila; Mohammad A Helwani; Arbi Ben Abdallah; Allan S Jaffe; Mitchell G Scott; Peter Nagele
Journal:  J Am Heart Assoc       Date:  2019-03-19       Impact factor: 5.501

5.  Potential predictors for mental stress-induced myocardial ischemia in patients with coronary artery disease.

Authors:  Mei-Yan Liu; Ya Yang; Li-Jun Zhang; Li-Hong Pu; Dong-Fang He; Jian-Yang Liu; Adam Hafeez; Yu-Chuan Ding; Huan Ma; Qing-Shan Geng
Journal:  Chin Med J (Engl)       Date:  2019-06-20       Impact factor: 2.628

6.  Highly sensitive troponin I assay in the diagnosis of coronary artery disease in patients with suspected stable angina.

Authors:  Indra Ramasamy
Journal:  World J Cardiol       Date:  2021-12-26

Review 7.  Biomarker Development in Cardiology: Reviewing the Past to Inform the Future.

Authors:  Katharine A Kott; Michael Bishop; Christina H J Yang; Toby M Plasto; Daniel C Cheng; Adam I Kaplan; Louise Cullen; David S Celermajer; Peter J Meikle; Stephen T Vernon; Gemma A Figtree
Journal:  Cells       Date:  2022-02-08       Impact factor: 6.600

8.  High-Sensitivity Cardiac Troponin I and the Diagnosis of Coronary Artery Disease in Patients With Suspected Angina Pectoris.

Authors:  Philip D Adamson; Amanda Hunter; Debbie M Madsen; Anoop S V Shah; David A McAllister; Tania A Pawade; Michelle C Williams; Colin Berry; Nicholas A Boon; Marcus Flather; John Forbes; Scott McLean; Giles Roditi; Adam D Timmis; Edwin J R van Beek; Marc R Dweck; Hans Mickley; Nicholas L Mills; David E Newby
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2018-02

9.  Use of High-Sensitivity Cardiac Troponin for the Exclusion of Inducible Myocardial Ischemia: A Cohort Study.

Authors:  Muhammad Hammadah; Jeong Hwan Kim; Ayman Samman Tahhan; Bryan Kindya; Chang Liu; Yi-An Ko; Ibhar Al Mheid; Kobina Wilmot; Ronnie Ramadan; Ayman Alkhoder; Fahad Choudhary; Mohamad Mazen Gafeer; Naser Abdelhadi; Pratik Pimple; Pratik Sandesara; Bruno B Lima; Amit J Shah; Laura Ward; Michael Kutner; J Douglas Bremner; David S Sheps; Paolo Raggi; Laurence S Sperling; Viola Vaccarino; Arshed A Quyyumi
Journal:  Ann Intern Med       Date:  2018-11-06       Impact factor: 25.391

10.  Another Unanswerable Question.

Authors:  Allan S Jaffe
Journal:  JACC Basic Transl Sci       Date:  2017-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.